J. Stern & Co’s Addex Therapeutics ADXN Stock Holding History

J. Stern & Co’s Portfolio ADXN Stock Details ADXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-107,827	Closed	-$151K	–	39
2023 Q4	$151K	Buy	+107,827	New	+$677K	0.03%	34

Other funds holding ADXN

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

J. Stern & Co's ADXN Position: Q1 2024 in Review

J. Stern & Co sold out of Addex Therapeutics (ADXN) in Q1 2024, closing a stake of 107,827 shares — an estimated $151K sold.

J. Stern & Co first reported a position in ADXN in Q4 2023 and held it in 1 quarter. The position peaked at $151K in Q4 2023. 1 fund tracked by Wall St. Rank holds ADXN as of Q1 2024.

J. Stern & Co reported no remaining Addex Therapeutics position as of Q1 2024 after selling out during the quarter.
J. Stern & Co sold 107,827 Addex Therapeutics shares in Q1 2024, an estimated $151K.
J. Stern & Co first reported a position in Addex Therapeutics in Q4 2023 and held it in 1 quarter.
J. Stern & Co's Addex Therapeutics position peaked at $151K in Q4 2023.
1 fund tracked by Wall St. Rank held Addex Therapeutics as of Q1 2024.

Based on J. Stern & Co's 13F filing for Q1 2024, filed 15 May 2024.